High Blood Pressure (Hypertension): Causes, Red Flags & Treatment

## Overview High blood pressure — clinically termed **hypertension** (ICD-10: I10) — is a chronic cardiovascular condition in which the force of blood against artery walls is persistently elevated. It is defined by the American College of Cardiology/American Heart Association (ACC/AHA) as a sustained systolic blood pressure (SBP) of **130 mm Hg or higher** or a diastolic blood pressure (DBP) of **80 mm Hg or higher** [1]. The earlier European threshold, still used in some guidelines, is 140/90 mm Hg [2]. Hypertension affects an estimated **1.28 billion adults worldwide** (WHO, 2021) and roughly **47 % of adults in the United States** under current ACC/AHA criteria [1]. It is the single largest modifiable risk factor for cardiovascular disease, stroke, chronic kidney disease, and premature death globally. Despite its prevalence, hypertension is often called the "silent killer" because most individuals experience **no obvious symptoms** until organ damage has already occurred. People commonly search for information on high blood pressure after receiving an elevated reading at a pharmacy kiosk, during a routine check-up, or after experiencing symptoms such as headache, dizziness, or nosebleeds — which may or may not be related to blood pressure. This article provides an evidence-based overview of causes, warning signs, self-care measures, medications, and clear guidance on when to seek medical attention. > **Disclaimer:** This article is for educational purposes only and does not replace professional medical advice. Always consult a qualified healthcare provider for diagnosis and treatment. --- ## Common Causes Hypertension is broadly classified into **primary (essential)** and **secondary** hypertension. ### 1. Primary (Essential) Hypertension (~90–95 % of cases) No single identifiable cause exists. Instead, a combination of genetic predisposition, environmental, and lifestyle factors drives a gradual increase in peripheral vascular resistance and arterial stiffness over years. **Key contributing mechanisms:** - **Excess dietary sodium** — promotes water retention and increases intravascular volume, raising cardiac output and, over time, vascular resistance [3]. - **Obesity and metabolic syndrome** — adipose tissue produces angiotensinogen and pro-inflammatory cytokines that activate the renin-angiotensin-aldosterone system (RAAS) and the sympathetic nervous system. - **Physical inactivity** — reduces nitric oxide–mediated vasodilation and impairs baroreceptor sensitivity. - **Chronic psychosocial stress** — sustained sympathetic activation raises heart rate and peripheral resistance. - **Aging** — progressive arterial stiffening (arteriosclerosis) increases systolic pressure, particularly after age 55. - **Genetic factors** — genome-wide association studies have identified over 1,000 loci linked to blood pressure regulation, each contributing small effects. - **Excess alcohol intake** — more than two standard drinks per day is associated with dose-dependent blood pressure elevation. ### 2. Secondary Hypertension (~5–10 % of cases) An identifiable underlying condition causes elevated pressure. Secondary causes should be suspected in patients with resistant hypertension, onset before age 30, or sudden worsening. | Cause | Mechanism | Clue to Diagnosis | |---|---|---| | **Chronic kidney disease** | Impaired sodium excretion, RAAS activation | Elevated creatinine, proteinuria | | **Renal artery stenosis** | Reduced renal perfusion triggers excess renin | Abdominal bruit, refractory hypertension | | **Primary aldosteronism** | Excess aldosterone causes sodium/water retention | Low potassium, adrenal nodule | | **Obstructive sleep apnea** | Intermittent hypoxia raises sympathetic tone | Snoring, daytime somnolence, obesity | | **Pheochromocytoma** | Catecholamine-secreting tumor | Episodic headache, sweating, palpitations | | **Thyroid disorders** | Hyperthyroidism increases cardiac output; hypothyroidism increases vascular resistance | Abnormal TSH | | **Coarctation of the aorta** | Mechanical narrowing proximal to renal arteries | Upper-limb hypertension, weak femoral pulses | | **Medications/substances** | NSAIDs, oral contraceptives, decongestants, stimulants, corticosteroids | Temporal association with drug use | --- ## RED FLAGS The following signs and symptoms may indicate a **hypertensive emergency** (SBP > 180 mm Hg and/or DBP > 120 mm Hg with acute organ damage) or another life-threatening condition. **Call emergency services (911) or go to the nearest emergency department immediately** if any of the following are present: - **Sudden severe headache** with confusion, visual changes, or difficulty speaking (possible stroke) - **Chest pain or pressure**, especially radiating to the arm, jaw, or back (possible acute coronary syndrome or aortic dissection) - **Sudden shortness of breath**, inability to lie flat, or pink frothy sputum (possible acute pulmonary edema) - **Sudden weakness or numbness** on one side of the body, facial droop, or slurred speech (stroke symptoms — use FAST assessment) - **Severe back or abdominal pain** that is sudden and tearing in quality (possible aortic dissection) - **Seizures or loss of consciousness** with known or suspected high blood pressure (hypertensive encephalopathy) - **Visual loss or severe blurred vision** of sudden onset - **Blood pressure reading above 180/120 mm Hg** on repeated measurement, even without symptoms — seek urgent medical evaluation - **New or worsening confusion, agitation, or lethargy** in a person with known hypertension - **Oliguria (very low urine output)** or dark/bloody urine with elevated blood pressure (acute kidney injury) > A single elevated reading without symptoms is generally **not** a hypertensive emergency but should still prompt medical follow-up within days. --- ## Self-Care at Home Lifestyle modifications are the **cornerstone** of blood pressure management and are recommended for all adults with elevated blood pressure, whether or not medications are prescribed [1][2]. Evidence-based non-pharmacological measures include: ### Dietary Approaches - **DASH diet (Dietary Approaches to Stop Hypertension)** — rich in fruits, vegetables, whole grains, and low-fat dairy; low in saturated fat and refined sugars. The landmark DASH trial demonstrated an average SBP reduction of **5.5 mm Hg** in normotensive and **11.4 mm Hg** in hypertensive participants [4]. - **Sodium restriction** — aim for **< 2,300 mg/day** (ideally < 1,500 mg/day for those with hypertension). A meta-analysis found that modest sodium reduction lowers SBP by approximately **5 mm Hg** in hypertensive individuals [3]. - **Increase potassium intake** — through foods such as bananas, spinach, sweet potatoes, and beans (unless contraindicated by kidney disease or potassium-sparing medications). Target: 3,500–5,000 mg/day from dietary sources. - **Limit alcohol** — no more than 2 standard drinks per day for men and 1 for women. Reducing alcohol intake can lower SBP by **2–4 mm Hg**. ### Physical Activity - **Aerobic exercise** — at least **150 minutes per week** of moderate-intensity activity (e.g., brisk walking, cycling, swimming). A meta-analysis of 93 trials found aerobic exercise reduces SBP by an average of **3.5 mm Hg** in the general population and more in hypertensive individuals [5]. - **Resistance training** — complementary benefit when combined with aerobic exercise; 2–3 sessions per week. - **Isometric exercise** — emerging evidence suggests isometric handgrip training may lower SBP by approximately 5–7 mm Hg, though guidelines do not yet formally recommend it as primary therapy. ### Weight Management - A weight loss of **1 kg** is associated with an approximate **1 mm Hg** reduction in SBP. For overweight or obese individuals, even modest weight loss (5–10 % of body weight) can have clinically meaningful effects. ### Stress Reduction - Techniques such as mindfulness meditation, deep breathing exercises, and cognitive-behavioral therapy may provide modest blood pressure reductions (generally 2–5 mm Hg). While evidence is less robust than for diet and exercise, these approaches are low risk and may benefit overall cardiovascular health. ### Other Measures - **Smoking cessation** — while smoking does not directly cause sustained hypertension, it acutely raises blood pressure, damages endothelium, and dramatically increases cardiovascular risk. - **Home blood pressure monitoring** — using a validated upper-arm cuff device, take readings in the morning and evening, seated, after 5 minutes of rest. Record and share results with your healthcare provider. --- ## OTC Medications That Help No over-the-counter medication is approved specifically for the chronic treatment of high blood pressure. However, some OTC products may play a supportive role or are relevant because of their interactions with blood pressure. | Class | Example | Typical Adult Dose | Notes | |---|---|---|---| | **Low-dose aspirin** | Aspirin 81 mg | 81 mg once daily | Not recommended for primary prevention of hypertension itself; may be used in secondary cardiovascular prevention under clinician guidance. Does not lower blood pressure. | | **Fish oil (omega-3 fatty acids)** | EPA/DHA supplements | 2–4 g/day of combined EPA+DHA | A meta-analysis suggests modest SBP reduction (~2–3 mm Hg) at higher doses. Generally well tolerated; may increase bleeding risk at very high doses. Consult clinician before use. | | **Magnesium supplements** | Magnesium oxide, citrate | 300–500 mg elemental Mg/day | May produce small BP reductions (~2 mm Hg) in deficient individuals. Can cause diarrhea. Avoid in severe renal impairment. | | **Coenzyme Q10 (CoQ10)** | Ubiquinone/ubiquinol | 100–200 mg/day | Some studies suggest modest SBP reduction; evidence is inconsistent. Generally safe. Should not replace proven therapies. | | **Potassium supplements** | Potassium chloride | Per label (typically 99 mg tablets OTC) | OTC doses are far below therapeutic range. Dietary potassium is preferred. Excess potassium is dangerous in renal impairment or with certain medications (ACE inhibitors, ARBs, potassium-sparing diuretics). | **Important OTC cautions:** - **NSAIDs** (ibuprofen, naproxen) can **raise blood pressure** by 3–5 mm Hg through sodium retention and renal prostaglandin inhibition. Use the lowest effective dose for the shortest duration, and monitor blood pressure. - **Pseudoephedrine and phenylephrine** (decongestants) are sympathomimetics that can significantly elevate blood pressure. Individuals with hypertension should generally **avoid** oral decongestants and opt for saline nasal sprays or intranasal corticosteroids instead. - **Caffeine-containing products** — may acutely raise blood pressure by 5–10 mm Hg in non-habitual users. Moderate, habitual caffeine use (≤ 400 mg/day) does not appear to cause sustained hypertension in most people. --- ## Prescription Options Pharmacological therapy is generally recommended when blood pressure remains at or above **130/80 mm Hg** (ACC/AHA) or **140/90 mm Hg** (ESC/ESH) despite lifestyle modifications, or immediately in individuals with established cardiovascular disease, diabetes, chronic kidney disease, or a 10-year atherosclerotic cardiovascular disease (ASCVD) risk ≥ 10 % [1][2]. Medications are prescribed by primary care physicians, internists, cardiologists, nephrologists, or other qualified clinicians. | Class | Examples | Mechanism | Typical Starting Dose | Key Notes | |---|---|---|---|---| | **ACE inhibitors** | Lisinopril, enalapril, ramipril | Block angiotensin-converting enzyme → reduce angiotensin II → vasodilation, reduced aldosterone | Lisinopril 10 mg once daily | First-line. Dry cough in ~10 %. Contraindicated in pregnancy. Monitor potassium and creatinine. | | **ARBs (Angiotensin II Receptor Blockers)** | Losartan, valsartan, irbesartan | Block AT1 receptors → similar effect to ACE inhibitors | Losartan 50 mg once daily | Alternative to ACE inhibitors (better tolerated — no cough). Contraindicated in pregnancy. | | **Calcium Channel Blockers (CCBs)** | Amlodipine, nifedipine (dihydropyridine); diltiazem, verapamil (non-dihydropyridine) | Block L-type calcium channels in vascular smooth muscle → vasodilation | Amlodipine 5 mg once daily | First-line. Peripheral edema common with dihydropyridines. Non-dihydropyridines may lower heart rate. | | **Thiazide / Thiazide-like Diuretics** | Hydrochlorothiazide (HCTZ), chlorthalidone, indapamide | Inhibit Na-Cl co-transporter in distal tubule → natriuresis → reduced plasma volume | Chlorthalidone 12.5–25 mg once daily | First-line. Chlorthalidone may be more effective than HCTZ. Monitor electrolytes (hypokalemia, hyponatremia) and uric acid. | | **Beta-blockers** | Metoprolol succinate, bisoprolol, carvedilol, nebivolol | Block beta-adrenergic receptors → reduce heart rate, cardiac output, and renin release | Metoprolol succinate 25–50 mg once daily | Not first-line for uncomplicated hypertension (per current guidelines). Preferred when comorbid heart failure, post-MI, or tachyarrhythmia. Avoid abrupt discontinuation. | | **Mineralocorticoid Receptor Antagonists (MRAs)** | Spironolactone, eplerenone | Block aldosterone receptors → natriuresis | Spironolactone 25 mg once daily | Useful in resistant hypertension. Spironolactone may cause gynecomastia; eplerenone is more selective. Monitor potassium closely. | | **Direct Renin Inhibitors** | Aliskiren | Inhibits renin → reduces angiotensin I formation | Aliskiren 150 mg once daily | Less commonly used. Do not combine with ACE inhibitors or ARBs (risk of hyperkalemia, renal impairment). Contraindicated in pregnancy. | | **Alpha-blockers** | Doxazosin, prazosin | Block alpha-1 adrenergic receptors → vasodilation | Doxazosin 1 mg at bedtime (titrate up) | Usually add-on therapy. First-dose hypotension risk. May benefit men with concurrent BPH. | | **Vasodilators** | Hydralazine, minoxidil | Direct smooth muscle relaxation | Hydralazine 25 mg three times daily | Reserved for resistant hypertension or specific situations (e.g., hydralazine in pregnancy). Reflex tachycardia common — often combined with beta-blocker. | **Combination therapy:** Many patients require **two or more agents** from different classes. The SPRINT trial demonstrated that targeting SBP < 120 mm Hg (intensive treatment) reduced major cardiovascular events by 25 % compared with a target of < 140 mm Hg, though with higher rates of adverse events such as hypotension and acute kidney injury [6]. --- ## Lab Tests Typically Ordered When hypertension is diagnosed, clinicians order baseline investigations to assess for target organ damage, identify secondary causes, and evaluate cardiovascular risk. | Test | Rationale | |---|---| | **Basic metabolic panel (BMP)** — sodium, potassium, creatinine, BUN, glucose | Assess kidney function, screen for electrolyte abnormalities (e.g., hypokalemia in primary aldosteronism), and identify diabetes. See [/tests/basic-metabolic-panel](/tests/basic-metabolic-panel). | | **Estimated GFR (eGFR)** | Quantify kidney function; chronic kidney disease is both a cause and consequence of hypertension. See [/tests/egfr](/tests/egfr). | | **Urinalysis with albumin-to-creatinine ratio** | Detect proteinuria/microalbuminuria — early marker of hypertensive nephropathy. See [/tests/urinalysis](/tests/urinalysis). | | **Lipid panel** (total cholesterol, LDL, HDL, triglycerides) | Assess overall cardiovascular risk for treatment decisions. See [/tests/lipid-panel](/tests/lipid-panel). | | **Fasting blood glucose and/or HbA1c** | Screen for diabetes mellitus, which significantly increases cardiovascular risk in hypertension. See [/tests/hba1c](/tests/hba1c). | | **Thyroid-stimulating hormone (TSH)** | Screen for thyroid disorders as a secondary cause. See [/tests/tsh](/tests/tsh). | | **12-lead ECG** | Detect left ventricular hypertrophy (LVH), arrhythmias, or ischemic changes — indicators of hypertensive heart disease. | | **Complete blood count (CBC)** | Baseline assessment; may reveal anemia (associated with CKD) or polycythemia. See [/tests/complete-blood-count](/tests/complete-blood-count). | | **Uric acid** | Elevated levels associated with hypertension and cardiovascular risk; also relevant before starting thiazide diuretics. | | **Plasma aldosterone/renin ratio** | Ordered when primary aldosteronism is suspected (resistant hypertension, hypokalemia). | | **Renal artery duplex ultrasound or CT angiography** | If renovascular hypertension is suspected. | | **24-hour ambulatory blood pressure monitoring (ABPM)** | Gold standard for confirming hypertension diagnosis and detecting white-coat or masked hypertension [2]. | --- ## Special Populations ### Children and Adolescents Hypertension in children is defined using **age-, sex-, and height-specific percentile tables** (≥ 95th percentile on three or more occasions). In adolescents ≥ 13 years, the adult threshold of 130/80 mm Hg may apply [7]. - **Causes** — more likely to be secondary (renal parenchymal disease, coarctation of the aorta) in younger children; primary hypertension is increasingly common in older children/adolescents, often linked to obesity. - **Treatment** — lifestyle modifications are first-line. Pharmacological therapy, when needed, should be initiated and managed by a pediatrician or pediatric nephrologist. **Specific drug doses for children should only be determined by a qualified pediatric clinician** based on weight and clinical context. - ACE inhibitors and ARBs are **contraindicated** in sexually active adolescents who may become pregnant. ### Pregnancy Hypertensive disorders of pregnancy (including gestational hypertension, preeclampsia, and eclampsia) complicate **5–10 %** of pregnancies and are a leading cause of maternal and fetal morbidity. - **Thresholds:** Blood pressure ≥ 140/90 mm Hg during pregnancy requires evaluation; severe hypertension (≥ 160/110 mm Hg) requires urgent treatment. - **Medications generally considered safer in pregnancy:** - **Labetalol** (combined alpha/beta-blocker) — commonly first-line - **Nifedipine** (extended-release) — widely used - **Methyldopa** — long safety record but less commonly first-line now - **Contraindicated in pregnancy (FDA/teratogenic risk):** - ACE inhibitors — **fetotoxic** (renal dysgenesis, oligohydramnios, skull ossification defects), especially in second and third trimesters - ARBs — same fetotoxic risks as ACE inhibitors - Direct renin inhibitors (aliskiren) - Nitroprusside (fetal cyanide toxicity) - **Preeclampsia** (hypertension + proteinuria or end-organ dysfunction after 20 weeks) may require **magnesium sulfate** for seizure prophylaxis and early delivery. ACOG recommends low-dose aspirin (81 mg/day) starting at 12–28 weeks for women at high risk of preeclampsia. - Postpartum: blood pressure should be monitored for at least 72 hours; some women develop new or worsening hypertension in the postpartum period. ### Elderly (≥ 65 years) - **Isolated systolic hypertension** (elevated SBP with normal or low DBP) is the most common pattern, driven by age-related arterial stiffening. - Treatment targets may be more conservative in frail older adults to avoid **orthostatic hypotension, falls, and syncope**. - Start medications at **lower doses** and titrate slowly ("start low, go slow"). - Diuretics and long-acting dihydropyridine CCBs (e.g., amlodipine) are generally well tolerated and evidence-based in this population. - The SPRINT trial included adults aged ≥ 75 years and demonstrated benefit of intensive BP lowering, though with careful monitoring [6]. ### Athletes - **Elevated blood pressure is common** during intense exertion (exercise-induced hypertension), but resting hypertension should still be evaluated and treated. - **Beta-blockers** are generally avoided in competitive athletes because they reduce exercise capacity and are banned in some sports (e.g., archery, shooting). ACE inhibitors, ARBs, and CCBs are generally preferred. - Diuretics are **prohibited substances** in many sporting organizations (WADA) due to masking potential and should be avoided in competitive athletes unless a Therapeutic Use Exemption (TUE) is obtained. - Regular aerobic training has an antihypertensive effect and should be encouraged, but athletes with severely uncontrolled hypertension (≥ 180/110 mm Hg) should **defer high-intensity competition** until blood pressure is better controlled. --- ## When to Escalate Use the following thresholds as a general guide. Individual circumstances may warrant earlier evaluation. | Urgency | Situation | Action | |---|---|---| | **Emergency (call 911 / go to ER)** | BP > 180/120 mm Hg **with** symptoms of organ damage: chest pain, shortness of breath, neurological deficits (weakness, speech difficulty, vision loss), severe headache with confusion, seizures, back pain suggesting dissection | Immediate emergency evaluation and IV antihypertensive therapy in a monitored setting. | | **Urgent / same-day evaluation** | BP > 180/120 mm Hg **without** symptoms (hypertensive urgency); or persistent BP > 160/100 mm Hg on home monitoring despite medications | Contact your healthcare provider urgently or visit urgent care. Oral antihypertensive adjustment is usually sufficient. | | **Routine GP appointment (within 1–2 weeks)** | Newly discovered BP of 130–159/80–99 mm Hg on repeated measurements; or need for medication adjustment due to side effects or suboptimal control | Schedule with your primary care provider. Bring home BP log. | | **Follow-up within 1 month** | Blood pressure at goal on current therapy; monitoring for medication side effects or lab abnormalities | Continue current plan, routine follow-up. | **Additional escalation triggers:** - New symptoms such as persistent headache, visual changes, ankle swelling, or exertional dyspnea in a person with known hypertension — may indicate developing target organ damage. - Resistant hypertension (BP above goal despite three antihypertensive agents at optimal doses, including a diuretic) — warrants referral to a hypertension specialist or nephrologist for secondary cause evaluation. - Suspected preeclampsia in a pregnant woman (new hypertension + headache, visual disturbances, upper abdominal pain, or lab abnormalities) — **seek immediate obstetric evaluation**. --- ## References [1] Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. *J Am Coll Cardiol*. 2018;71(19):e127–e248. PMID:29146535. [2] Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. *Eur Heart J*. 2018;39(33):3021–3104. PMID:30165516. [3] He FJ, Li J, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. *BMJ*. 2013;346:f1325. PMID:23558162. [4] Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. *N Engl J Med*. 1997;336(16):1117–1124. PMID:9099655. [5] Cornelissen VA, Smart NA. Exercise training for blood pressure: a systematic review and meta-analysis. *J Am Heart Assoc*. 2013;2(1):e004473. PMID:23525435. [6] SPRINT Research Group, Wright JT Jr, Williamson JD, et al. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. *N Engl J Med*. 2015;373(22):2103–2116. PMID:26551272. [7] Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. *Pediatrics*. 2017;140(3):e20171904. PMID:28827377. [8] National Institute for Health and Care Excellence (NICE). Hypertension in adults: diagnosis and management. NICE Guideline NG136. Published August 2019, updated March 2022. Available at: https://www.nice.org.uk/guidance/ng136. [9] American College of Obstetricians and Gynecologists (ACOG). Gestational Hypertension and Preeclampsia. ACOG Practice Bulletin No. 222. *Obstet Gynecol*. 2020;135(6):e237–e260. PMID:32443079. [10] Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. *JAMA*. 2003;289(19):2560–2572. PMID:12748199.